FMP
Inspire Medical Systems, Inc.
INSP
NYSE
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
186.29 USD
-1.29 (-0.692%)
We are unable to load the chart at this time.
Mr. Timothy P. Herbert
Healthcare
Medical - Devices
NYSE
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
0001609550
US4577301090
457730109
5500 Wayzata Boulevard
844 672 4357
US
1,011
May 3, 2018
We are unable to load the chart at this time.
We are unable to load the chart at this time.
0001609550
NYSE
Medical - Devices
Healthcare
457730109
US4577301090
US
186.29
1.36
485.16k
5.58B
-
123.0-257.4
-104.63
-
-
-
-
167.83
-
https://www.inspiresleep.com
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.